Nevertheless, GSH is commonly used as a liver-protective drug after chemotherapy for breast cancer patients to mitigate chemotherapy-induced hepatotoxicity
Chanez-Paredes SD, Abtahi S, Kuo W-T, Turner JR (2021) Differentiating between tight junction-dependent and tight junction-independent intestinal barrier loss in vivo
Therefore, they wrote, our findings may be explained by evidence suggesting that GLP-1RAs exert their effects, in part, by regulating several proinflammatory pathways. In summary, while this study suggests GLP-1 therapy for patients with type 2 diabetes may portend a reduced risk of incident AMD and slow progression of AMD, future research is needed to validate these findings, as well as investigate the drugs effect on AMD in non-diabetic patients
Survival signalling in the preimplantation embryo
A study has been launched to look into a potential genetic risk after hundreds of people reported problems with their pancreas after taking weight loss drugs